Michael A. Choti

Active 1990–2019

177
Papers
46,053
Citations
112
h-index
169
i10-index

Citations

Citations per year for Michael A. Choti1939: 1 citations1982: 1 citations1985: 1 citations1991: 2 citations1992: 2 citations1993: 3 citations1994: 3 citations1995: 1 citations1996: 1 citations1997: 3 citations1998: 5 citations1999: 13 citations2000: 28 citations2001: 33 citations2002: 78 citations2003: 103 citations2004: 92 citations2005: 115 citations2006: 144 citations2007: 193 citations2008: 258 citations2009: 311 citations2010: 283 citations2011: 359 citations2012: 421 citations2013: 501 citations2014: 592 citations2015: 650 citations2016: 603 citations2017: 602 citations2018: 514 citations2019: 1,658 citations2020: 1,627 citations2021: 1,374 citations2022: 921 citations2023: 582 citations2024: 931 citations2025: 366 citations2026: 12 citations1940–1981: no citations, so these years are not shown1983–1984: no citations, so these years are not shown1986–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,977 citing papers, 28.1% of this breakdownChina: 1,666 citing papers, 9.4% of this breakdownItaly: 1,178 citing papers, 6.7% of this breakdownGermany: 1,031 citing papers, 5.8% of this breakdownUnited Kingdom: 983 citing papers, 5.5% of this breakdownJapan: 901 citing papers, 5.1% of this breakdownFrance: 769 citing papers, 4.3% of this breakdownNetherlands: 696 citing papers, 3.9% of this breakdownCanada: 647 citing papers, 3.7% of this breakdownSpain: 421 citing papers, 2.4% of this breakdownAustralia: 419 citing papers, 2.4% of this breakdownSouth Korea: 374 citing papers, 2.1% of this breakdown
0%28.1%Other 20.6%

Fields

  • Medicine67.6%
  • Biochemistry, Genetics and Molecular Biology26%
  • Engineering2.8%
  • Immunology and Microbiology0.9%
  • Computer Science0.8%
  • Health Professions0.3%
  • Other1.6%

Topics

  • Cancer Genomics and Diagnostics8%
  • Pancreatic and Hepatic Oncology Research7.9%
  • Cholangiocarcinoma and Gallbladder Cancer Studies5.6%
  • Hepatocellular Carcinoma Treatment and Prognosis5.6%
  • Gallbladder and Bile Duct Disorders3.1%
  • Neuroendocrine Tumor Research Advances2.7%
  • Other67.1%

Coauthors

All papers

Open in search
  1. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Calogero Lauricella, Michael Lim, Evan J. Lipson, Suely Kazue Nagahashi Marie, George J. Netto, Kelly S. Oliner, Alessandro Olivi, Louise Olsson, Gregory J. Riggins, Andrea Sartore‐Bianchi, Kerstin Schmidt, le-Ming Shih, Sueli Mieko Oba‐Shinjo, Salvatore Siena, Dan Theodorescu, Jeanne Tie, Timothy T. Harkins, Silvio Veronese, Tian‐Li Wang, Jon Weingart, Christopher L. Wolfgang, Laura D. Wood, Dongmei Xing, Ralph H. Hruban, Jian Wu, Peter J. Allen, C. Max Schmidt, Michael A. Choti, Victor E. Velculescu, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Luis A. Díaz - Science Translational Medicine 2014 cited by 5,110

  2. Circulating mutant DNA to assess tumor dynamics

    Authors: , , , , , , , , , , , , - Nature Medicine 2008 cited by 2,713

  3. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

    Authors: , , , , , , , , , , , , , , - Nature Communications 2015 cited by 1,148

  4. DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors

    Authors: , , , , , , , , , , , , , , , - Science 2011 cited by 1,718

  5. Cholangiocarcinoma

    Authors: , , , , , , , , - Annals of Surgery 2007 cited by 1,294

  6. Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 cited by 746

  7. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors

    Authors: , , , , , , , , - Clinical Epidemiology 2012 cited by 667

  8. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 637

  9. Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis

    Authors: , , , , , , , , , - Journal of Clinical Oncology 2016 cited by 397

  10. A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers

    Authors: , , , , , , , , , , , - Annals of Surgery 2013 cited by 489

  11. Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma

    Authors: , , , , , , , , , , , , , - Journal of Gastrointestinal Surgery 2012 cited by 550

  12. Readiness of US General Surgery Residents for Independent Practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Surgery 2017 cited by 336

  13. Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis

    Authors: , , , , , , , , , - Annals of Surgery 2009 cited by 791

  14. Association Between Specific Mutations inKRASCodon 12 and Colorectal Liver Metastasis

    Authors: , , , , , , , , , - JAMA Surgery 2015 cited by 163

  15. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis

    Authors: , , , , , , , , , , , - HPB 2011 cited by 409

  16. The Feasibility of Real-Time Intraoperative Performance Assessment With SIMPL (System for Improving and Measuring Procedural Learning): Early Experience From a Multi-institutional Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of surgical education 2016 cited by 213

  17. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer

    Authors: , , , , , , , , , , - Surgery 2007 cited by 449

  18. The effect of gender on operative autonomy in general surgery residents

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Surgery 2019 cited by 137

  19. Robotic Versus Laparoscopic Pancreaticoduodenectomy: a NSQIP Analysis

    Authors: , , , , , , , , - Journal of Gastrointestinal Surgery 2017 cited by 94

  20. 1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience

    Authors: , , , , , , , , , , , , , - Journal of Gastrointestinal Surgery 2006 cited by 1,482

  21. Surgical Management of Hepatic Neuroendocrine Tumor Metastasis: Results from an International Multi-Institutional Analysis

    Authors: , , , , , , , , , , , , , , , , , , , , - Annals of Surgical Oncology 2010 cited by 476

  22. Impact of Total Lymph Node Count and Lymph Node Ratio on Staging and Survival after Pancreatectomy for Pancreatic Adenocarcinoma: A Large, Population-Based Analysis

    Authors: , , , , , , , - Annals of Surgical Oncology 2007 cited by 364

  23. Recurrence after operative management of intrahepatic cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Surgery 2013 cited by 290

  24. Behavior of Tip-Steerable Needles in Ex Vivo and In Vivo Tissue

    Authors: , , , , , , - IEEE Transactions on Biomedical Engineering, IEEE Trans. Biomed. Eng. 2012 cited by 90